Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

6.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.7K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

84
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
84

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical conflict of advanced practice providers related to drug testing and reporting for maternity patients with opioid use disorder.

Journal of substance use and addiction treatment·2026
Same author

Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.

BMJ open·2026
Same author

An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Buprenorphine prescribing is increasingly delivered by primary care nurse practitioners to Medicaid beneficiaries.

Journal of the American Association of Nurse Practitioners·2026
Same author

A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol.

Contemporary clinical trials·2025
Same author

Patient-Related Barriers to Chronic Pain Management Among Cancer Survivors: A Narrative Synthesis.

Research square·2025

Related Experiment Video

Updated: Apr 9, 2026

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.8K

Responsible opioid use.

Peggy Compton, Michael F Weaver

    Journal of Pain & Palliative Care Pharmacotherapy
    |June 23, 2015
    PubMed
    Summary
    This summary is machine-generated.

    This study examines prescription opioid abuse, identifying distinct patient populations and emphasizing the critical need for responsible prescribing practices to mitigate addiction risks, especially in vulnerable communities.

    Keywords:
    addictionopioidspainsubstance abuse

    More Related Videos

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
    12:20

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

    Published on: June 10, 2013

    22.1K
    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
    10:13

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

    Published on: November 8, 2024

    3.0K

    Related Experiment Videos

    Last Updated: Apr 9, 2026

    Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
    09:54

    Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

    Published on: March 8, 2020

    5.8K
    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
    12:20

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

    Published on: June 10, 2013

    22.1K
    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
    10:13

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

    Published on: November 8, 2024

    3.0K

    Area of Science:

    • Pain Management and Addiction Medicine
    • Public Health and Epidemiology

    Background:

    • Prescription opioid abuse affects distinct populations: those developing addiction from pain treatment and those using opioids primarily for abuse.
    • Untreated opioid addiction leads to poor patient outcomes, necessitating a focus on contextual factors in treatment.

    Purpose of the Study:

    • To review patterns of prescription opioid abuse in vulnerable populations, particularly in underserved rural areas.
    • To outline principles of responsible opioid prescription for chronic pain to reduce addiction risk.

    Main Methods:

    • Review of existing literature and data on prescription opioid abuse patterns.
    • Analysis of contextual factors contributing to problematic opioid use.
    • Synthesis of principles for responsible opioid prescribing.

    Main Results:

    • Identified two primary pathways to prescription opioid abuse.
    • Highlighted poor outcomes associated with untreated opioid addiction.
    • Emphasized the importance of addressing contextual factors in treatment and prevention.

    Conclusions:

    • Responsible opioid prescribing is crucial for preventing addiction.
    • Targeted interventions are needed for vulnerable populations, including those in rural communities.
    • Integrating pain management and addiction control strategies is essential for effective patient care.